Moneycontrol PRO
Register now: Moneycontrol & Property Share present a webinar on Wealth Generation Through Commercial Real Estate on Thursday, 30th March 2023 | 5 pm onwards.

Buy Torrent Pharmaceuticals; target of Rs 1788: Sharekhan

Sharekhan is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1788 in its research report dated March 16, 2023.

March 17, 2023 / 01:19 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan's research report on Torrent Pharmaceuticals

Torrent Pharma’s average sales growth stood at 13.5% (for January and February), beating the Indian Pharma Market’s (IPM’s) 11.3% growth for the same period. On a MAT basis, sales grew by 15.5% for February 2023 versus the IPM’s 8.2%. Torrent Pharma’s IPM-based average revenue growth run rate for Q4FY23E is in line with our estimate of 13.0%. We, hence, maintain our overall revenue and earnings growth estimates at 12.3% and 19.5% CAGR over FY2022-FY2025E, respectively. Key markets such as India and Brazil will continue to support revenue growth while Curatio’s acquisition will aid margin expansion.

Outlook

Stock trades at 31.3x/24.5x its FY24E/FY25E EPS estimates. We maintain a Buy on Torrent Pharma with an unchanged PT of Rs. 1,788.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Torrent Pharmaceuticals - 17 -03 - 2023 - moti

Broker Research
first published: Mar 17, 2023 01:19 pm